I know from experience that Rituximab was recommended by one of the Renal doctors. But also know it is not for everyone.
It's good to get some opposing view to challenge the thesis. I don't know why everyone so sensitive about this.
I see Rituximab as the cheaper and more affordable option before people look at the Dimerix offering.
Ann: Investor Presentation, page-100
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.020(4.35%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.5¢ | 44.0¢ | $628.7K | 1.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 132686 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 21213 | 4 |
View Market Depth
| Last trade - 11.41am 30/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |